ZTS (Zoetis) Total Current Assets : $6,282 Mil (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Zoetis Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Zoetis's total current assets for the quarter that ended in Sep. 2024 was $6,282 Mil.

Zoetis Total Current Assets Historical Data

The historical data trend for Zoetis's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zoetis Total Current Assets Chart

Zoetis Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Current Assets

Get a 7-Day Free Trial

4,748.00

6,611.00

6,930.00

7,506.00

6,343.00

Zoetis Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Current Assets	Get a 7-Day Free Trial															6,222.00	6,343.00	6,359.00	6,202.00	6,282.00

Zoetis Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Zoetis's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	2039	+	1304	+	2564	+	436
	=	6,343

Zoetis's Total Current Assets for the quarter that ended in Sep. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1710	+	1411	+	2416	+	745
	=	6,282

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Zoetis (NYSE:ZTS) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Zoetis's Liquidation Value for the quarter that ended in Sep. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1710	-	9123	+	0.75 * 1411	+	0.5 * 2416
=	-5,147

Zoetis Total Current Assets Related Terms

Thank you for viewing the detailed overview of Zoetis's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Zoetis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (NYSE:ZTS) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

ZTS:Mexico 1ZTS:Italy 0M3Q:UK ZOE:Germany Z1TS34:Brazil ZOTS:Austria

Address

10 Sylvan Way, Parsippany, NJ, USA, 07054

Website

https://www.zoetis.com

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Executives

Robert J Polzer	officer: Executive Vice President	C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Roxanne Lagano	officer: Executive Vice President	C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Willie M Reed	director	C/O ZOETIS, 100 CAMPUS DRIVE, FLORHAM PARK NJ 07932
Kristin C Peck	officer: Executive Vice President	C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Heidi C. Chen	officer: Executive Vice President	C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Soria Ester Banque	officer: Executive Vice President	C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Rimma Driscoll	officer: Executive Vice President	C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Jamie Brannan	officer: Executive Vice President	C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Vanessa Broadhurst	director	ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933
Nicholas Ashton	officer: Executive Vice President	C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Roman Trawicki	officer: Executive Vice President	C/O ZOETIS INC., 100 CAMPUS DRIVE, FLORHAM PARK NJ 07932
Glenn David	officer: SVP and Acting CFO	C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Astorga Jeannette Ferran	officer: Executive Vice President	C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Catherine A. Knupp	officer: Executive Vice President	C/O ZOETIS INC., 100 CAMPUS DRIVE, FLORHAM PARK NJ 07940
Gregory Norden	director	16640 CHESTERFIELD GROVE DRIVE, SUITE 200, CHESTERFIELD MO 63005